That is the title of the podcast episode I was on for AJMC’s Managed Care Cast. We discuss my recently published paper on insurance value in Duchenne’s Muscular Dystrophy (DMD). To learn more about research in DMD, check out AJMC’s DMD compendia page. The full podcast is below.
Similar Posts
Flavonoid Supplement Health Benefits
Your diet-conscious friend might have suggested you add up flavonoid-rich foods to your diet owing to…
Do patients value improvements in progression-free survival? – Healthcare Economist
Progression-free survival (PFS) is a surrogate endpoint is defined as follows (by ChatGPT): In essence, PFS…
Do State Out-Of-Pocket Caps On Insulin Costs Improve Access? – Healthcare Economist
Perhaps not. At least that is according to a paper by Anderson et al. (2024). The…
The Hidden Dangers of Commercial Hand Sanitisers (and the one I recommend) | Brenda Janschek Health & Lifestyle
During this age of Coronavirus when it’s hard to get to a tap to wash hands…
Links – Healthcare Economist
South Park on the American health care system Social science genomics. Blood donation or high interest…
Cultural Challenges to the Much-Needed Digital Revolution in Healthcare Supply Chain Management – MedCity News
The pandemic was a disaster for healthcare supply chains in the United States – and all…
